Skip to main content
  • Asia Pacific
  • MedTech

How to Conduct a Known Problems Analysis (KPA) for NMPA Compliance

Emergo by UL Human Factors Specialists discuss the specific requirements the National Medical Products Association (NMPA) has set forth for known problems analyses.

  • EMEA
  • MedTech

Making the European Medical Device Nomenclature (EMDN) complete

Are you a medical device manufacturer doing business in Europe? Learn more about European Medical Device Nomenclature and why is it important for medical device manufacturers.

  • North America
  • MedTech

US FDA CDRH Warning Letters: A Review of 2024

Medical device manufacturers who want to better understand U.S. FDA warning letters should read our regulatory insight.

  • North America
  • MedTech

US FDA CDRH 2024 Annual Report Summary

Medical device manufacturers can read our summary of the 2024 Annual Report recently released by the U.S. FDA’s Center for Devices and Radiological Health.

  • North America
  • MedTech

US FDA Rules for Notification of Discontinuation or Meaningful Interruption in Manufacturing

The U.S. Food & Drug Administration has finalized guidance requiring manufacturers to notify it of discontinuations or meaningful interruptions in manufacturing for many devices during, or in advance of, a public health emergency.

Open Q&A forum: Maximizing Human Factors in Early Product Development

Our senior human factors engineering (HFE) and design experts answer questions about how to strategically approach discovery and design activities early on in product development.

  • EMEA
  • MedTech

MHRA Releases Suite of Guidance for New Post-Market Surveillance Regulation

The Medicines and Healthcare products Regulatory Agency (MHRA) announced the release of a suite of post-market surveillance (PMS) guidance (January 15).

  • Asia Pacific
  • MedTech

Malaysia MDA Announces Agreement with China NMPA

This agreement paves the way for facilitating medical device market access for manufacturers between Malaysia and China.

  • Asia Pacific

Australian TGA Expands EU Transitional IVDR Arrangements for New Inclusion IVD Applications

Are you a manufacturer applying to register a medical device or IVD with the Australian Register of Therapeutic Goods (ARTG)? Now you have more options to fulfill the Manufacturer Evidence requirement to support an application.

Software

Emergo by UL offers digital applications, human factors engineering (HFE) platform, Optimal Product Usability Suite (OPUS) and Regulatory Affairs Management Suite, RAMS.